University of Pittsburgh School of Medicine

New Capabilities

Lead institution for the CHIPS trial

A 1,000-patient trial published in JAMA found that platelets chilled for up to 21 days control surgical bleeding as well as standard room-temperature platelets. Standard units expire after 5 to 7 days, and since testing eats the first two, the usable window is just 3 to 5 days.

Updated Oct 13

New Capabilities

As of September 2026: Lead institution for the study

Alzheimer's disease scrambles the three-dimensional folding of DNA inside brain cells, a study published in Science on July 23 reports. It's the first single-cell map of how the disease reshapes the genome's architecture across the brain.

Updated Sep 13

New Capabilities

As of September 2026: Co-led the OBERON and TITANIA trials

Millions of COPD patients who don't respond to current biologic treatments may soon have a new option. AstraZeneca's tozorakimab cut moderate-to-severe flare-ups by 29% to 34% in two late-stage trials, and unlike existing biologics, it worked across all blood eosinophil levels.

Updated Sep 10